SANWAY GENE
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79398160
- Registration number
- 7656782
- Mark type
- Design + words
- Filed
- 05 Jan 2024
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 005 — Pharmaceuticals: Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and of the genitourinary system, for the prevention and treatment of infectious diseases, viral diseases, and inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, and ophthalmology and for the treatment of gastroenterological disorders; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes; reagents for use in medical genetic testing; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, and pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal tissue diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; demineralised water for medical purposes; diagnostic kits comprised of medical diagnostic reagents for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting diseases related to cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, and oncological disorders of the digestive system, blood system, reproductive system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biological preparations for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system and for the treatment of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; antibiotic tablets; allergy tablets; chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposes, namely, anti-itch ointments, hemorrhoidal ointments
- Class 010 — Medical apparatus: Surgical apparatus and instruments; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for immunoassay analysis, apparatus for organ and tissue cavitation detecting, and apparatus for medical imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus, for use with computer displays and computer monitors and for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; genetic testing apparatus for medical purposes; medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection all for medical diagnostic purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for testing DNA and RNA samples
Owner
Prosecution history
- 05 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 19 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 19 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 29 Aug 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 Aug 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Aug 2025 — FINAL DISPOSITION PROCESSED
- 22 Apr 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE